WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 70.30
+0.30 (0.43%)
Jul 30, 2026, 10:30 AM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.18 billion as of July 29, 2026. Its market cap has increased by 7.69% in one year.
Market Cap
3.18B
Enterprise Value
3.68B
Revenue
1.14B
Ranking
n/a
PE Ratio
15.17
Stock Price
70.30
ChartMarket Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.18B, a decrease of -7.19%. That is a compound annual growth rate of -2.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.18B | -4.63% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 6.61B |
| Hi-Clearance | 5.81B |
| Applied BioCode | 3.08B |
| Bonraybio | 2.85B |
| Wellell | 2.51B |
| A Plus Biotechnology | 2.46B |
| Medimaging Integrated Solution | 2.29B |
| OK Biotech | 2.11B |